BL Pharmtech Corp. (KOSDAQ: 065170)

Market Cap	20.82B
Revenue (ttm)	11.94B
Net Income (ttm)	4.56B
Shares Out	8.90M
EPS (ttm)	510.56
PE Ratio	4.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	725,916
Open	1,920.00
Previous Close	1,890.00
Day's Range	1,920.00 - 2,390.00
52-Week Range	189.00 - 2,390.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About BL Pharmtech

BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd. BL Pharmtech Corp. was founded in 1995 and is headquartered in Yongin, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 14
• Stock Exchange: KOSDAQ
• Ticker Symbol: 065170

Financial Performance

In 2023, BL Pharmtech's revenue was 24.53 billion, an increase of 8.89% compared to the previous year's 22.52 billion. Losses were -148.85 million, -98.93% less than in 2022.